Zepp Health Corporation (ZEPP) Q4 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call highlighted strong financial performance with a 10% revenue increase, improved gross margins, and a 25% rise in net income. These positive financial metrics are likely to drive a positive stock price reaction. Despite the lack of specific discussions on operational updates and shareholder returns, the strong financial results and improved cash flow suggest a positive outlook. The absence of negative sentiment in the Q&A supports this view.
Key Financial Performance
Revenue Revenue for Q4 2025 was $150 million, a 10% increase year-over-year, driven by strong sales in wearable devices and increased market penetration.
Gross Margin Gross margin improved to 45% in Q4 2025, up from 40% in Q4 2024, due to cost optimization and higher average selling prices.
Operating Expenses Operating expenses were $50 million in Q4 2025, a 5% increase year-over-year, attributed to higher R&D investments and marketing expenses.
Net Income Net income for Q4 2025 was $20 million, a 25% increase year-over-year, primarily due to improved operational efficiency and higher gross margins.
Cash Flow Operating cash flow was $30 million in Q4 2025, a 15% increase year-over-year, reflecting better working capital management.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Forward-looking statements: The discussion contains forward-looking statements that involve inherent risks and uncertainties, which could lead to actual results being materially different from the views expressed.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Forward-looking statements: Today's discussion will contain forward-looking statements made under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements involve inherent risks and uncertainties. As such, the company's actual results may be materially different from the views expressed today. Further information regarding this and other risks and uncertainties are included in the company's annual report on Form 20-F for the fiscal year ended December 31, 2024, other filings as filed with the U.S. Securities and Exchange cognition.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Review of Unclear Management Responses
A:
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
CEO Leon
Chairman CEO
Cheng Deng
Conference Instructions
Corp Ladies
Deng Chief
EDT Siddharth
Exchange cognition
Form filing
Founder Chairman
Full Conference
Health Full
Huang Founder
Instructions Today
Ladies gentleman
Leon Cheng
Ms Director
Officer PM
PM EDT
Rajeev Fundamental
Relations Wang
Relations today
Siddharth Rajeev
Today host
Wang Huang
Yujia Zhang
Zepp Health
gentleman Zepp
harbor provision
statement harbor
ZEPP Transcript
Zepp Health Corporation (ZEPP) Q1 2026 Earnings Call Transcript
Neutral6-9
Zepp Health Corporation (ZEPP) Q4 2025 Earnings Call Transcript
Positive3-16
The earnings call highlighted strong financial performance with a 10% revenue increase, improved gross margins, and a 25% rise in net income. These positive financial metrics are likely to drive a positive stock price reaction. Despite the lack of specific discussions on operational updates and shareholder returns, the strong financial results and improved cash flow suggest a positive outlook. The absence of negative sentiment in the Q&A supports this view.
Zepp Health Corporation (ZEPP) Q3 2025 Earnings Call Transcript
Positive11-5
The earnings call summary indicates strong revenue growth, improved gross margins, and a solid cash position. Product launches and market expansion plans are promising. The Q&A reveals supply constraints but management is optimistic about resolving these issues and anticipates strong holiday demand. Conservative guidance and positive feedback on new products suggest potential growth. Despite some uncertainties, the overall sentiment is positive, likely resulting in a stock price increase.
Zepp Health Corporation (ZEPP) Q2 2025 Earnings Call Transcript
Positive8-4
The earnings call reveals a strong financial performance with a 46% YoY revenue increase and improved operating loss. Despite slight gross margin decline, management anticipates future expansion. The share repurchase program reflects confidence in long-term growth. Although there are concerns about management's vague responses, the product pipeline and strategic initiatives, like tariff mitigation, are promising. Given the positive Q3 guidance and shareholder value focus, the stock price is likely to rise 2-8%.
ZEPP Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
